1
2
Mar. 29, 2022 —Infections with hepatitis C and E are so common that, going only by statistics, many people should be infected with both viruses at the same time. However, only very few such cases have been ...
Feb. 18, 2022 —Researchers report that patients with chronic hepatitis C who are treated with direct-acting antiviral medicines are less likely to be hospitalized or seek emergency care for liver and non-liver ...
Mar. 20, 2023 —In 2020, bulevirtide (BLV) was conditionally approved for treating chronic hepatitis delta (CHD), an inflammation of the liver caused by hepatitis D virus (HDV). Now real-world studies of patients ...
Mar. 2, 2022 —As of today, there is no vaccine against hepatitis C. To improve the search for it, researchers are looking for a so-called surrogate model: an animal that can also suffer from viral hepatitis and ...
Sep. 21, 2022 —The risk of heart attack was about 30% higher with each decade of age as people with HIV got older. However, that risk increased 85% with each decade among people who also have untreated hepatitis C, ...
Mar. 17, 2021 —The discovery of a previously unknown hepatitis B virus in donkeys and zebras opens up new opportunities for understanding the course of the disease. A global research consortium was able to show ...
Feb. 4, 2021 —Around 260 million people, more than three percent of the global population, are chronically infected with the hepatitis B virus (HBV); in the long term, this often leads to complications such as ...
Nov. 3, 2022 —Even after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in advanced liver disease. Researchers have shown that the ...
Oct. 21, 2022 —A three-dose course of the hepatitis B vaccine HEPLISAV-B fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to new ...
Feb. 15, 2022 —Researchers have developed a new scoring system to help health care professionals predict the 30-day mortality risk for patients with alcohol-associated hepatitis, and the tool appears to more ...